CK activity in plasma of 2 myopathic patients treated with 1 or 2 g IVIG/kg body weight in the first cycle. CK activities in plasma of patient L (▵), treated with 2 g, and of patient I (▴) treated with 1 g IVIG/kg body weight. The figure shows the relative CK activity profiles.